Back
Catalyst Pharmaceuticals Vs. Summit Therapeutics Industry Stock Comparison
Buy
60
CPRX
Catalyst Pharmaceuticals
Last Price:
23.91
Seasonality Move:
-2.02%
Buy
65
SMMT
Summit Therapeutics
Last Price:
21.41
Seasonality Move:
43.75%
Buy
60
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $23.93. The Score for CPRX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $21.41. The Score for SMMT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $23.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $21.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.71 | Buy |
| Relative Strength Index (14 RSI): | 78.86 | Buy |
| Chaikin Money Flow: | 387024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.33 - 22.37) | Buy |
| Bollinger Bands (100): | (16.75 - 21.29) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 54.59 | Buy |
| Chaikin Money Flow: | 421167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.05 - 21.57) | Buy |
| Bollinger Bands (100): | (9.09 - 21.39) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.36 | Buy |
| 20-day SMA: | 21.71 | Buy |
| 50-day SMA: | 20.72 | Buy |
| 200-day SMA: | 17.19 | Buy |
| 8-day EMA: | 22.61 | Buy |
| 20-day EMA: | 21.83 | Buy |
| 50-day EMA: | 20.77 | Buy |
| 200-day EMA: | 17.89 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20 | Buy |
| 20-day SMA: | 20.63 | Buy |
| 50-day SMA: | 20.55 | Buy |
| 200-day SMA: | 9.96 | Buy |
| 8-day EMA: | 20.63 | Buy |
| 20-day EMA: | 20.49 | Buy |
| 50-day EMA: | 19.23 | Buy |
| 200-day EMA: | 11.98 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.10 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.08 per share.
Catalyst Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||